Anetta Matera

Evaluation of pharmacogenomics and hepatic nuclear imaging–related covariates by population pharmacokinetic models of irinotecan and its metabolites

Jennifer H. Martin, M. Jefford, I. Campbell, 2021, European Journal of Clinical Pharmacology.

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

N. Lawrentschuk, D. Murphy, M. Frydenberg, 2020, The Lancet.

Evaluation of pharmacogenomics and hepatic nuclear imaging–related covariates by population pharmacokinetic models of irinotecan and its metabolites

M. Jefford, R. Hicks, C. Karapetis, 2021, European Journal of Clinical Pharmacology.

A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer

J. Zalcberg, V. Ganju, M. Michael, 2008, British Journal of Cancer.